Key result
Highly sensitive cardiac troponin assays are powerful prognostic biomarkers in the general population, correlating strongly with future heart failure risk, cardiovascular death, and subclinical heart disease.
Why the study?
Do highly sensitive cardiac troponin assays predict cardiovascular risk in the general population?
Population
General population
Design
Review
Authors
Loading...
Troponin levels may enhance CV risk prediction in general populations; leaves open whether screening alters management or outcomes.
Do highly sensitive cardiac troponin assays predict cardiovascular risk in the general population?
Highly sensitive cardiac troponin assays are powerful prognostic biomarkers for predicting heart failure and cardiovascular death in the general population.
Lemos et al. (2013) conducted a review in General population. Highly sensitive cardiac troponin assays was evaluated. Highly sensitive cardiac troponin assays are powerful prognostic biomarkers in the general population, correlating strongly with future heart failure risk, cardiovascular death, and subclinical heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: